CJC-1295 WITH DAC 2mg

CJC-1295 With DAC is a high-purity synthetic research peptide available at Revo Peptide, supplied at ≥98% purity and rigorously verified by HPLC and mass spectrometry analysis. This compound is presented as a lyophilized white powder, formulated exclusively for in vitro and laboratory research applications. For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.

Product Overview

CJC-1295 With DAC (Drug Affinity Complex) is a synthetic analogue of growth hormone-releasing hormone (GHRH). The incorporation of the Drug Affinity Complex technology — specifically a maleimide-lysine conjugate — enables prolonged binding to endogenous albumin, significantly extending the compound’s half-life compared to its non-DAC counterpart. This characteristic makes CJC-1295 With DAC a subject of considerable interest in peptide pharmacology research, particularly in studies examining sustained GHRH receptor engagement and downstream signaling pathways. Revo Peptide offers this compound for sale to qualified laboratory researchers seeking a reliable, analytically verified source.

Peptide Structure & Amino Acid Sequence

CJC-1295 With DAC is a 30-amino acid peptide with the following confirmed sequence:

H-Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-Lys(Mal)-NH2

The terminal maleimide modification on the lysine residue (Lys(Mal)) is the defining structural feature that enables covalent binding to cysteine-34 of serum albumin in biological systems. This structural detail is central to research investigating long-acting GHRH analogues and their receptor pharmacodynamics.

Chemical & Physical Characteristics

• Molecular Formula: C₁₆₅H₂₆₉N₄₇O₄₆
• Molecular Weight: 3,647.19 g/mol
• Appearance: White lyophilized powder
• Peptide Purity: ≥98% (batch-verified ≥99%)
• Solubility: Soluble in aqueous buffers; sterile water or acetic acid solutions recommended for laboratory reconstitution
• Storage Condition: −20°C (long-term); 2–8°C (short-term, post-reconstitution)

Purity & Analytical Verification (HPLC & MS)

Every batch of CJC-1295 With DAC supplied by Revo Peptide undergoes comprehensive analytical testing prior to release. High-performance liquid chromatography (HPLC) is employed to confirm peptide purity at ≥98%, while mass spectrometry (MS) validates the molecular weight and structural integrity of the compound. These dual-verification protocols ensure that researchers receive a product meeting the highest standards of analytical quality expected in modern peptide science.

Quality Control & Lyophilization Integrity

The lyophilization process used in the preparation of CJC-1295 With DAC preserves the peptide’s structural integrity, prevents degradation during transit, and extends shelf stability. Each vial is sealed under inert conditions to minimize oxidative exposure. Revo Peptide’s quality control pipeline includes identity confirmation, purity assessment, and physical inspection of every production batch before it is made available for purchase online.

Safety, Handling & Laboratory Precautions

CJC-1295 With DAC is intended exclusively for use by trained laboratory professionals in controlled research environments. Researchers should adhere to standard laboratory safety protocols when handling lyophilized peptides, including the use of appropriate personal protective equipment (PPE). This compound should not be administered to humans or animals under any circumstances. Store away from moisture, heat, and direct light. Avoid repeated freeze-thaw cycles once reconstituted in a laboratory setting.

Reconstitution, Packaging & Storage

CJC-1295 With DAC is supplied as a lyophilized powder in sealed, single-use vials. For laboratory reconstitution purposes, sterile aqueous solutions are commonly used in research protocols. Reconstituted solutions should be stored at 2–8°C and used within a timeframe consistent with validated laboratory procedures. Long-term storage of unreconstituted vials is recommended at −20°C. Packaging is designed to maintain integrity during international shipping and ambient temperature fluctuations.

Intended Research Use & Market Positioning

CJC-1295 With DAC is positioned as a premium-grade research tool for scientists investigating GHRH receptor biology, peptide half-life extension mechanisms, albumin-binding pharmacology, and related endocrine research fields. It is not intended for use as a pharmaceutical, nutraceutical, or consumable product. Revo Peptide supplies this compound exclusively to researchers, academic institutions, and licensed laboratory professionals.

Ordering, Availability & Fulfillment

Revo Peptide offers CJC-1295 With DAC for sale online with streamlined ordering, competitive best-price positioning, and reliable international fulfillment. Bulk ordering options are available for qualified research institutions requiring larger quantities. Orders are processed promptly, with each vial dispatched in protective packaging to ensure product integrity upon arrival. Order now through the Revo Peptide online store for fast, discreet, and professionally managed delivery.

Legal & Regulatory Disclaimer

For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications. CJC-1295 With DAC is sold exclusively as a laboratory research reagent. Purchasers are solely responsible for ensuring compliance with all applicable local, national, and international regulations governing the acquisition, storage, and use of research peptides. Revo Peptide makes no representations regarding the safety, efficacy, or suitability of this compound for any use beyond controlled laboratory research. This product has not been evaluated or approved by any regulatory authority for therapeutic or clinical use.